Perillaldehyde pretreatment alleviates cerebral ischemia-reperfusion injury by improving mitochondrial structure and function via the Nrf2/Keap1/Trx2 axis DOI
Ji Liu, Ying Han,

Zhiyun Wu

et al.

Phytomedicine, Journal Year: 2024, Volume and Issue: 136, P. 156328 - 156328

Published: Dec. 15, 2024

Language: Английский

Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets DOI Creative Commons
Meng Zhang, Qian Liu, Hui Meng

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: Jan. 8, 2024

Abstract Ischemia-reperfusion (I/R) injury paradoxically occurs during reperfusion following ischemia, exacerbating the initial tissue damage. The limited understanding of intricate mechanisms underlying I/R hinders development effective therapeutic interventions. Wnt signaling pathway exhibits extensive crosstalk with various other pathways, forming a network system pathways involved in injury. This review article elucidates signaling, as well complex interplay between and including Notch, phosphatidylinositol 3-kinase/protein kinase B, transforming growth factor-β, nuclear factor kappa, bone morphogenetic protein, N-methyl-D-aspartic acid receptor-Ca 2+ -Activin A, Hippo-Yes-associated toll-like receptor 4/toll-interleukine-1 domain-containing adapter-inducing interferon-β, hepatocyte factor/mesenchymal-epithelial transition factor. In particular, we delve into their respective contributions to key pathological processes, apoptosis, inflammatory response, oxidative stress, extracellular matrix remodeling, angiogenesis, cell hypertrophy, fibrosis, ferroptosis, neurogenesis, blood-brain barrier damage Our comprehensive analysis reveals that activation canonical promotes organ recovery, while non-canonical exacerbates Moreover, explore novel approaches based on these mechanistic findings, incorporating evidence from animal experiments, current standards, clinical trials. objective this is provide deeper insights roles its I/R-mediated processes dysfunction, facilitate innovative agents for

Language: Английский

Citations

165

Novel Insight into the Modulatory Effect of Traditional Chinese Medicine on Cerebral Ischemia-Reperfusion Injury by Targeting Gut Microbiota: A Review DOI Creative Commons

Yushan Ren,

Gang Chen, Ying Hong

et al.

Drug Design Development and Therapy, Journal Year: 2025, Volume and Issue: Volume 19, P. 185 - 200

Published: Jan. 1, 2025

Abstract: Cerebral ischemia-reperfusion injury (CIRI) is clinically characterized by high rates of morbidity, disability, mortality, and recurrence as well economic burden. The clinical manifestations CIRI are often accompanied gastrointestinal symptoms such intestinal bacterial dysbiosis bleeding. Gut microbiota plays an important role in the pathogenesis CIRI, its potential biological effects have received extensive attention. gut not only affects barrier function but also regulates immunity host homeostasis. Traditional Chinese medicine (TCM), a multi-component multi-targeted drug, has shown remarkable few adverse reactions prevention treatment CIRI. Notably, effect TCM on regulating maintaining homeostasis gradually become hot topic. This review summarizes functional development progression therapeutic improving dysbiosis, affecting metabolism, immunity. active ingredients used for relevant studies were saponins, triterpenoids, phenolics, alkaloids. In addition, to treat briefly discussed. established significance prospects TCM-based treatments provided necessary theoretical support further resources Keywords: cerebral injury, ischemic stroke, gut-brain axis, microbiota, traditional

Language: Английский

Citations

1

Baicalin attenuates the immune escape of oral squamous cell carcinoma by reducing lactate accumulation in tumor microenvironment DOI Creative Commons

Yameng Cui,

Jingwen Liu, Xi Wang

et al.

Journal of Advanced Research, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

1

SIRT3 facilitates mitochondrial structural repair and functional recovery in rats after ischemic stroke by promoting OPA1 expression and activity DOI
Hongbin Chen, Ji Liu,

Manli Chen

et al.

Clinical Nutrition, Journal Year: 2024, Volume and Issue: 43(7), P. 1816 - 1831

Published: June 6, 2024

Language: Английский

Citations

6

Advances in Nanomedicines: A Promising Therapeutic Strategy for Ischemic Cerebral Stroke Treatment DOI
Jun Li, Fei Xie, Xuemei Ma

et al.

Nanomedicine, Journal Year: 2024, Volume and Issue: 19(9), P. 811 - 835

Published: March 6, 2024

Ischemic stroke, prevalent among the elderly, necessitates attention to reperfusion injury post treatment. Limited drug access brain, owing blood–brain barrier, restricts clinical applications. Identifying efficient carriers capable of penetrating this barrier is crucial. Blood–brain transporters play a vital role in nutrient transport brain. Recently, nanoparticles emerged as carriers, enhancing permeability via surface-modified ligands. This article introduces structure, elucidates pathogenesis, compiles ischemic stroke treatment drugs, explores nanomaterials for encapsulation and emphasizes their advantages over conventional drugs. Utilizing drug-delivery systems offers targeting efficiency benefits absent traditional The prospects nanomedicine are promising.

Language: Английский

Citations

5

Mechanism of Astragalus mongholicus Bunge ameliorating cerebral ischemia-reperfusion injury: Based on network pharmacology analysis and experimental verification DOI
Rui Li, Qi Lou, Tingting Ji

et al.

Journal of Ethnopharmacology, Journal Year: 2024, Volume and Issue: 329, P. 118157 - 118157

Published: April 6, 2024

Language: Английский

Citations

5

Tanshinone IIA Against Cerebral Ischemic Stroke and Ischemia- Reperfusion Injury: A Review of the Current Documents DOI
Reza Arefnezhad,

Alireza Nejabat,

Fatemeh Behjati

et al.

Mini-Reviews in Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 24(18), P. 1701 - 1709

Published: March 14, 2024

Abstract:: Stroke is a well-known neurological disorder that carries significant morbidity and mortality rates worldwide. Cerebral Ischemic (CIS), the most common subtype of stroke, occurs when thrombosis or emboli form elsewhere in body travel to brain, leading reduced blood perfusion. Ischemia/Reperfusion Injury (CIRI) complication CIS arises flow rapidly restored brain tissue after period ischemia. The therapeutic approaches currently recognized for CIS, such as thrombolysis thrombectomy, have notable side effects limit their clinical application. Recently, there has been growing interest among researchers exploring potential herbal agents treating various disorders malignancies. One agent with medicinal applications tanshinone IIA, an active diterpene quinone extracted from Salvia miltiorrhiza Bunge. Tanshinone IIA shown several pharmacological benefits, including anti-inflammatory, antioxidant, anti-apoptotic, neuroprotective properties. Multiple studies indicated protective role CIRI. This literature review aims summarize current findings regarding molecular mechanisms through which this compound improves

Language: Английский

Citations

4

Metabolomic and transcriptomic analyses revealed potential mechanisms of Anchusa italica Retz. in alleviating cerebral ischemia–reperfusion injury via Wnt/β-catenin pathway modulation DOI Creative Commons

Wenjie Tan,

Shuo Fu, Yufei Wang

et al.

Natural Products and Bioprospecting, Journal Year: 2025, Volume and Issue: 15(1)

Published: Jan. 8, 2025

Abstract Anchusa italica Retz. (AIR), a traditional herbal remedy, is commonly applied in managing heart and brain disorders. However, its specific function mechanism acute cerebral ischemia–reperfusion injury (CIRI) are not fully understood. This research focused on the interventional effects potential mechanisms of AIR extract (AIRE) rat model CIRI. The was established using filament occlusion method, which involved blocking middle artery for 1.5 h then removing to restore blood flow. Transcriptomic metabolomic analyses were conducted explore molecular pathways metabolites affected by AIRE. ATP level measured an assay kit. Additionally, RT-qPCR western blot tests evaluate influence AIRE Wnt signaling pathway mitochondrial function. indicated that regulated CIRI modulated associated with energy metabolism, such as citrate succinate. result demonstrated enhanced production Further, revealed activated Wnt/β-catenin corrected dysfunction. These results proposed mitigated metabolism deficits via pathway. By restoring balance might offer potentially therapeutic strategy addressing Graphical

Language: Английский

Citations

0

A novel PDE4 inhibitor ZX21011 alleviates neuronal apoptosis by decreasing GSK3β-mediated Drp1 Ser616 phosphorylation in cerebral ischemia reperfusion DOI

Huizhen Wen,

Xingxing Tu,

Fulan Luo

et al.

Chemico-Biological Interactions, Journal Year: 2025, Volume and Issue: unknown, P. 111405 - 111405

Published: Jan. 1, 2025

Language: Английский

Citations

0

Exploring the Therapeutic Mechanism of Xinbao Pill in Brain Injury After Cardiopulmonary Resuscitation Based on Network Pharmacology, Metabolomics, and Experimental Verification DOI Creative Commons
Dongli Li, Qihui Wu,

Zunjiang Li

et al.

CNS Neuroscience & Therapeutics, Journal Year: 2025, Volume and Issue: 31(3)

Published: March 1, 2025

Post-cardiopulmonary resuscitation brain injury (PBI) is essentially the cerebral ischemia reperfusion (CIR) injury, which main cause of death and long-term disability in patients with cardiac arrest. So far, there no treatment for PBI; thus, it urgent to develop new drugs or therapies prevention after cardiopulmonary resuscitation. Although multiple constituent herbs active ingredients Xinbao Pill (XBP) have shown neuroprotective effects, whether XBP could play a therapeutic role on PBI still unknown. This study aimed illustrate effect probe underlying mechanisms. We first performed cell animal experiments validate protective neurological function. next identified potential differential metabolites via metabolomics analysis. further conducted comprehensive network pharmacology analysis including overlap gene analysis, protein-protein interaction network, gene-biological process-module function preliminarily investigate specific mechanism action (MOA) against PBI. Finally, PCR, MTT, ELISA assay, as well Western blotting were made our proposed molecular The vitro experiment showed that increase viability ameliorate morphological damage PC12 cells exposed oxygen-glucose deprivation reoxygenation (OGD/RO) conditions. vivo demonstrated improved Neurologic Deficit Score (NDS), lowered Neuron-Specific Enolase (NSE) level reversed typical neuropathological changes rats, indicating its Further 94 treatment, highly related CIR. Moreover, results revealed may be relevant mitochondrial quality control (MQC). Mechanistically, not only promote expressions marker proteins PGC1α, NRF1, TFAM, OPA1, MFN1 MFN2 biogenesis fusion but also inhibit those containing DRP1, MFF, FIS1, p62, PINK1, Parkin LC3 fission mitophagy. AMP-activated protein kinase (AMPK) inhibitor was crucial regulating MQC. Our determined might an anti-PBI formula, deciphered MOAs by approach combined experimental validation.

Language: Английский

Citations

0